None listed
Conditions
Brief summary
The study involves the addition of skin glue to the insertion site of a routinely inserted peripheral intravenous line (IVL) which is expected to reduce the IVL failure rate, by reducing the combined poor outcomes of Infection, Phlebitis, Occlusion and/or Dislodgement, in those patients that are admitted to hospital.
Interventions
The study will involve patients in the Emergency Department who already have an IVL insitu secured by a standard dressing and are admitted and awaiting a bed on the wards within the hospital.
The research team will identify and consent these patients if they are otherwise eligible and fit the inclusion criteria.
If a patient is randomised to receive skin glue then their original dressing will be removed, glue applied to the IVL and allowed to dry (mater of minutes) before a new standard dressin
The study will involve patients in the Emergency Department who already have an IVL insitu secured by a standard dressing and are admitted and awaiting a bed on the wards within the hospital. The research team will identify and consent these patients if they are otherwise eligible and fit the inclusion criteria. If a patient is randomised to receive skin glue then their original dressing will be removed, glue applied to the IVL and allowed to dry (mater of minutes) before a new standard dressing is applied back over the top of the IVL. The skin glue applied is single use therefore one per patient used once only. If they are randomised to the control group then they will simply have their current standard dressing removed and replaced with another standard dressing. The research team will look at failure (IPOD) of the first IVL inserted in the patient by following the patient up either within the hospital or by telephoning them 48hrs after application of the dressing they have been randomised too. Those patients randomised to the intervention group will receive skin glue plus standard dressing to secure the IVL.
Sponsors
Dr. Simon Bugden
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
-Informed written consent by patient or legal decision maker -Presence of either a pre-hospital (Queensland Ambulance Service) inserted upper limb IVL or clinical indication for an Emergency Department inserted upper limb IVL. -Decision by Emergency Department staff that patient is to be admitted to hospital therefore IVL expected to be in place greater than 24 hours. -Patient aged 18years or over.
Exclusion criteria
If the patient is considered to be or have any of the following then they will be excluded from the study. -Is less than 18 years of age. -History of allergy or irritation to either standard IVL. insertion materials or skin glue. -IVL inserted through non-intact (eg area of abrasion or blistering) or diaphoretic skin (too sweaty to enable dressing adhesion). -Pre-existing upper limb phlebitis, infection, venous thrombosis. -Agitated patients wo are likely to pull IVL out.
Outcome results
None listed